Anika Resch

Neuropsychological Outcome of Children Treated for Standard Risk Medulloblastoma in the PNET4 European Randomized Controlled Trial of Hyperfractionated Versus Standard Radiation Therapy and Maintenance Chemotherapy

Hugo Câmara‐Costa, Anika Resch, Virginie Kieffer et al. · International Journal of Radiation Oncology*Biology*Physics · 2015 · 44 citations

Medicine, Oncology, Pediatrics +17

Treatment of Children With Central Nervous System Primitive Neuroectodermal Tumors/Pinealoblastomas in the Prospective Multicentric Trial HIT 2000 Using Hyperfractionated Radiation Therapy Followed by Maintenance Chemotherapy

Nicolas U. Gerber, Katja von Hoff, Anika Resch et al. · International Journal of Radiation Oncology*Biology*Physics · 2014 · 44 citations

Medicine, Oncology, Pediatrics +15

Treatment of children under 4 years of age with medulloblastoma and ependymoma in the HIT2000/HIT-REZ 2005 trials: Neuropsychological outcome 5 years after treatment

Holger Ottensmeier, Paul G. Schlegel, Matthias Eyrich et al. · PLoS ONE · 2020 · 23 citations · Full text

Medicine, Oncology, Pediatrics +14

Quality of survival and cognitive performance in children treated for medulloblastoma in the PNET 4 randomized controlled trial

Hugo Câmara‐Costa, Kim Bull, Colin Kennedy et al. · Neuro-Oncology Practice · 2017 · 15 citations · Full text

Medicine, Child Health, Pediatrics +17